Belumosudil (Rezurock)

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Mechanism of action

ROCK2 (Rho-associated coiled-coil kinase 2) inhibitor

Diseases for which it is used

History of changes in FDA indication

  • 7/16/2021: Approved for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy. (Based on KD025-213)

Also known as

  • Code names: KD025, SLx-2119
  • Brand name: Rezurock